The in-depth studies reported that IgG3 antibodies specific to MSP3 are associated with clinical malaria protection, using sera from people in hyperendemic areas, aged 0-15 or older in Myanmar (43), and aged 0-21 or older in Senegal (44). Here, IGHG3 is linked to malaria.